Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Observational Non-Interventional Study (NIS) to Assess Patient Characteristics and Healthcare Resource Use (HCRU) Among COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir (PAXLOVID TM) in the Kingdom of Saudi Arabia (KSA).

NCT06016556 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06016556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06016556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Observational Non-Interventional Study (NIS) to Assess Patient Characteristics and Healthcare Resource Use (HCRU) Among COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir (PAXLOVID TM) in the Kingdom of Saudi Arabia (KSA).
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 17, 2023
Completion date
April 9, 2024
Enrollment
250 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19